Stay updated on Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Sign up to get notified when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.

Latest updates to the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedMinor platform update: Revision: v3.4.2 added and Revision: v3.4.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check21 days agoChange DetectedMinor site revision updating from v3.4.0 to v3.4.1 with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedThe update adds a glossary toggle and updates UI/metadata labels, including capitalization changes for QC criteria text and the No FEAR Act Data label, and upgrades the revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4 on the page header, indicating a minor maintenance update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedThe Study Details page reorganizes location data by removing the state-specific 'Florida Locations', 'Michigan Locations', and 'Texas Locations' subsections and introducing a general 'Locations' section. This update (revision v3.3.3) changes how locations are presented to users.SummaryDifference0.3%

- Check85 days agoChange DetectedRevision: v3.3.2 replaces the previous v3.3.1. This appears to be a minor update with no visible changes to page content or layout.SummaryDifference0.0%

Stay in the know with updates to Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Azacitidine±Nivolumab/Midostaurin in Older AML Clinical Trial page.